3-n-butylphthalide has been researched along with Cerebral Small Vessel Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, XF; Qi, YY; Qiu, L; Yang, F | 1 |
| Chen, S; Chen, X; Chen, Y; Chu, L; Dong, W; Fang, B; Guo, H; Han, X; Huang, L; Jia, J; Jia, Q; Li, D; Liang, J; Lv, P; Niu, X; Peng, D; Peng, M; Song, H; Wang, K; Wei, C; Wu, J; Wu, L; Zhang, J; Zhou, A; Zuo, X | 1 |
1 trial(s) available for 3-n-butylphthalide and Cerebral Small Vessel Diseases
| Article | Year |
|---|---|
The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double-blind, placebo-controlled trial.
Topics: Aged; Benzofurans; Cerebral Small Vessel Diseases; China; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests | 2016 |
1 other study(ies) available for 3-n-butylphthalide and Cerebral Small Vessel Diseases
| Article | Year |
|---|---|
3-n-butylphthalide inhibits the apoptosis of nerve cells in rats with cerebral small vessel disease via the PI3K/Akt pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Behavior, Animal; Benzofurans; Brain Chemistry; Carotid Artery Diseases; Caspase 3; Cerebral Small Vessel Diseases; Male; Maze Learning; Neurons; Neuroprotective Agents; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction | 2019 |